Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Wellbutrin SR)
350 results
  • Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis. [Review]
    J Gen Intern Med 2019Chan B, Kondo K, … Kansagara D
  • CONCLUSIONS: Most of the pharmacotherapies studied were not effective for treating cocaine use disorder. Bupropion, psychostimulants, and topiramate may improve abstinence, and antipsychotics may improve retention. Contingency management and behavioral interventions along with pharmacotherapy should continue to be explored.
  • Pharmacotherapy of obesity - state of the art. [Review]
    Endokrynol Pol 2018; 69(4)Matyjaszek-Matuszek B, Szafraniec A, Porada D
  • Obesity, which affects about 13% of the world population, results in significant deterioration of health and serious clinical, mainly meta-bolic and cardiovascular complications. Although the basis of therapeutic treatment is behavioural treatment, often non-pharmacological effects do not produce the desired effect. Currently there are several drugs with a safe action profile that improve the eff…
  • Drugs and Lactation Database (LactMed): Bupropion [BOOK]
    National Library of Medicine (US): Bethesda (MD)BOOK
  • Limited information indicates that maternal bupropion doses of up to 300 mg daily produce low levels in breastmilk and would not be expected to cause any adverse effects in breastfed infants. However, there is little reported use in breastfed newborn infants and case reports of a possible seizure in partially breastfed 6-month-olds. If bupropion is required by a nursing mother, it is not a reason…
  • Effect of combined naltrexone and bupropion therapy on the brain's functional connectivity. [Journal Article]
    Int J Obes (Lond) 2018; 42(11):1890-1899Wang GJ, Zhao J, … Volkow ND
  • CONCLUSIONS: NB32 treatment decreased local and global FCD in superior parietal cortex and increased its connectivity with ACC (involved with saliency attribution), insula (interoception), and decreased local FCD in the medial prefrontal cortex (craving), which might underlie NB32 improved control over eating behaviors. NCT00711.
New Search Next